ドライアイ症候群治療薬のグローバル市場2023~2027:小売薬局、病院薬局、オンライン薬局

【英語タイトル】Global Dry Eye Syndrome Drugs Market 2023-2027

Technavioが出版した調査資料(IRTNTR46644-23)・商品コード:IRTNTR46644-23
・発行会社(調査会社):Technavio
・発行日:2023年5月23日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の調査レポートによると、世界のドライアイ症候群治療薬市場規模が、予測期間中(2022-2027年)にCAGR 6.53%増加し、2,159.21百万ドルへ到達すると推測されています。本レポートでは、ドライアイ症候群治療薬の世界市場を総合的に調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模・予測、過去の市場規模、ファイブフォース分析、流通チャネル別(小売薬局、病院薬局、オンライン薬局)分析、製品別(一般医薬品、処方薬)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、イギリス、日本、ドイツ、中国)分析、成長要因・課題・動向、企業状況、企業分析などの内容をまとめています。並びに、市場調査の対象企業には、Abbott Laboratories、AbbVie Inc.、AFT Pharmaceuticals Ltd.、Akorn Operating Co. LLC、Bausch Health Co. Inc.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、I MED Pharma Inc.、Johnson and Johnson Services Inc.、Laboratoires THEA SASなどが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界のドライアイ症候群治療薬市場規模:流通チャネル別
- 小売薬局チャネルの市場規模
- 病院薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・世界のドライアイ症候群治療薬市場規模:製品別
- 一般医薬品の市場規模
- 処方薬の市場規模
・顧客状況
・世界のドライアイ症候群治療薬市場規模:地域別
- 北米のドライアイ症候群治療薬市場規模
- ヨーロッパのドライアイ症候群治療薬市場規模
- アジアのドライアイ症候群治療薬市場規模
- その他地域のドライアイ症候群治療薬市場規模
- アメリカのドライアイ症候群治療薬市場規模
- イギリスのドライアイ症候群治療薬市場規模
- 日本のドライアイ症候群治療薬市場規模
- ドイツのドライアイ症候群治療薬市場規模
- 中国のドライアイ症候群治療薬市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益・価格・競争・プロモーションなどの肝要な変数の分析をし、多種の情報源からのデータを調査、統合、および総括することにより、ドライアイ症候群治療薬市場の明細な全容を示します。主要産業のインフルエンサーを限定することにより、市場の様々な側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確なドライアイ症候群治療薬市場の成長を推測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選定手法と分析を提供します。

ドライアイ症候群治療薬の世界市場 2023-2027

ドライアイ症候群治療薬市場は、2022年から2027年にかけて2,159.21百万米ドルの成長が予測され、予測期間中のCAGRは6.53%で加速すると予測されます。
当レポートでは、ドライアイ症候群治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。高齢者人口の増加、医療費の増加、ライフスタイルの変化、ドライアイ症候群の原因となる疾患の増加などが市場を牽引しています。

Technavio社のドライアイ症候群治療薬市場は以下のように分類されています:

・流通チャネル別:
– 小売薬局
– 病院薬局
– オンライン薬局

・製品別:
– 一般用医薬品
– 処方薬

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間のドライアイ症候群治療薬市場の成長を牽引する主な要因の一つとして、薬物送達技術の進歩を挙げています。また、ドライアイ症候群の診断技術の進歩や、ドライアイ症候群治療薬の個別化医療へのシフトは、市場の大きな需要につながるでしょう。

当レポートでは、ドライアイ症候群治療薬市場について以下の領域をカバーしています:
– ドライアイ症候群治療薬の市場規模
– ドライアイ症候群治療薬市場予測
– ドライアイ症候群治療薬市場の産業分析

確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, AbbVie Inc., AFT Pharmaceuticals Ltd., Akorn Operating Co. LLC, Bausch Health Co. Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, I MED Pharma Inc., Johnson and Johnson Services Inc., Laboratoires THEA SAS, Mitotech SA, Novaliq GmbH, Novartis AG, Oasis Medical Inc., Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., and Visufarmaなどの企業情報が含まれています。また、ドライアイ症候群治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global dry eye syndrome drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global dry eye syndrome drugs market 2017 – 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Retail pharmacies – Market size and forecast 2022-2027
o Exhibit 34: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o 6.4 Hospital pharmacies – Market size and forecast 2022-2027
o Exhibit 38: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacies – Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product – Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 OTC drugs – Market size and forecast 2022-2027
o Exhibit 52: Chart on OTC drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on OTC drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on OTC drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on OTC drugs – Year-over-year growth 2022-2027 (%)
o 7.4 Prescription drugs – Market size and forecast 2022-2027
o Exhibit 56: Chart on Prescription drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Prescription drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Prescription drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Prescription drugs – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 87: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Japan – Market size and forecast 2022-2027
o Exhibit 91: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 111: Abbott Laboratories – Overview
o Exhibit 112: Abbott Laboratories – Business segments
o Exhibit 113: Abbott Laboratories – Key news
o Exhibit 114: Abbott Laboratories – Key offerings
o Exhibit 115: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 116: AbbVie Inc. – Overview
o Exhibit 117: AbbVie Inc. – Product / Service
o Exhibit 118: AbbVie Inc. – Key news
o Exhibit 119: AbbVie Inc. – Key offerings
o 12.5 AFT Pharmaceuticals Ltd.
o Exhibit 120: AFT Pharmaceuticals Ltd. – Overview
o Exhibit 121: AFT Pharmaceuticals Ltd. – Business segments
o Exhibit 122: AFT Pharmaceuticals Ltd. – Key offerings
o Exhibit 123: AFT Pharmaceuticals Ltd. – Segment focus
o 12.6 Bausch Health Co. Inc.
o Exhibit 124: Bausch Health Co. Inc. – Overview
o Exhibit 125: Bausch Health Co. Inc. – Business segments
o Exhibit 126: Bausch Health Co. Inc. – Key news
o Exhibit 127: Bausch Health Co. Inc. – Key offerings
o Exhibit 128: Bausch Health Co. Inc. – Segment focus
o 12.7 I MED Pharma Inc.
o Exhibit 129: I MED Pharma Inc. – Overview
o Exhibit 130: I MED Pharma Inc. – Product / Service
o Exhibit 131: I MED Pharma Inc. – Key offerings
o 12.8 Johnson and Johnson Services Inc.
o Exhibit 132: Johnson and Johnson Services Inc. – Overview
o Exhibit 133: Johnson and Johnson Services Inc. – Business segments
o Exhibit 134: Johnson and Johnson Services Inc. – Key news
o Exhibit 135: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 136: Johnson and Johnson Services Inc. – Segment focus
o 12.9 Laboratoires THEA SAS
o Exhibit 137: Laboratoires THEA SAS – Overview
o Exhibit 138: Laboratoires THEA SAS – Product / Service
o Exhibit 139: Laboratoires THEA SAS – Key offerings
o 12.10 Mitotech SA
o Exhibit 140: Mitotech SA – Overview
o Exhibit 141: Mitotech SA – Product / Service
o Exhibit 142: Mitotech SA – Key offerings
o 12.11 Novaliq GmbH
o Exhibit 143: Novaliq GmbH – Overview
o Exhibit 144: Novaliq GmbH – Product / Service
o Exhibit 145: Novaliq GmbH – Key offerings
o 12.12 Novartis AG
o Exhibit 146: Novartis AG – Overview
o Exhibit 147: Novartis AG – Business segments
o Exhibit 148: Novartis AG – Key offerings
o Exhibit 149: Novartis AG – Segment focus
o 12.13 Oasis Medical Inc.
o Exhibit 150: Oasis Medical Inc. – Overview
o Exhibit 151: Oasis Medical Inc. – Product / Service
o Exhibit 152: Oasis Medical Inc. – Key offerings
o 12.14 Otsuka Holdings Co. Ltd.
o Exhibit 153: Otsuka Holdings Co. Ltd. – Overview
o Exhibit 154: Otsuka Holdings Co. Ltd. – Business segments
o Exhibit 155: Otsuka Holdings Co. Ltd. – Key offerings
o Exhibit 156: Otsuka Holdings Co. Ltd. – Segment focus
o 12.15 Santen Pharmaceutical Co. Ltd.
o Exhibit 157: Santen Pharmaceutical Co. Ltd. – Overview
o Exhibit 158: Santen Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 159: Santen Pharmaceutical Co. Ltd. – Key offerings
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 160: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 161: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 162: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. – Overview
o Exhibit 164: Viatris Inc. – Business segments
o Exhibit 165: Viatris Inc. – Key news
o Exhibit 166: Viatris Inc. – Key offerings
o Exhibit 167: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global dry eye syndrome drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Product – Market share 2022-2027 (%)
Exhibits49: Data Table on Product – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on OTC drugs – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on OTC drugs – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on OTC drugs – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on OTC drugs – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Prescription drugs – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Prescription drugs – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Prescription drugs – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Prescription drugs – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abbott Laboratories – Overview
Exhibits112: Abbott Laboratories – Business segments
Exhibits113: Abbott Laboratories – Key news
Exhibits114: Abbott Laboratories – Key offerings
Exhibits115: Abbott Laboratories – Segment focus
Exhibits116: AbbVie Inc. – Overview
Exhibits117: AbbVie Inc. – Product / Service
Exhibits118: AbbVie Inc. – Key news
Exhibits119: AbbVie Inc. – Key offerings
Exhibits120: AFT Pharmaceuticals Ltd. – Overview
Exhibits121: AFT Pharmaceuticals Ltd. – Business segments
Exhibits122: AFT Pharmaceuticals Ltd. – Key offerings
Exhibits123: AFT Pharmaceuticals Ltd. – Segment focus
Exhibits124: Bausch Health Co. Inc. – Overview
Exhibits125: Bausch Health Co. Inc. – Business segments
Exhibits126: Bausch Health Co. Inc. – Key news
Exhibits127: Bausch Health Co. Inc. – Key offerings
Exhibits128: Bausch Health Co. Inc. – Segment focus
Exhibits129: I MED Pharma Inc. – Overview
Exhibits130: I MED Pharma Inc. – Product / Service
Exhibits131: I MED Pharma Inc. – Key offerings
Exhibits132: Johnson and Johnson Services Inc. – Overview
Exhibits133: Johnson and Johnson Services Inc. – Business segments
Exhibits134: Johnson and Johnson Services Inc. – Key news
Exhibits135: Johnson and Johnson Services Inc. – Key offerings
Exhibits136: Johnson and Johnson Services Inc. – Segment focus
Exhibits137: Laboratoires THEA SAS – Overview
Exhibits138: Laboratoires THEA SAS – Product / Service
Exhibits139: Laboratoires THEA SAS – Key offerings
Exhibits140: Mitotech SA – Overview
Exhibits141: Mitotech SA – Product / Service
Exhibits142: Mitotech SA – Key offerings
Exhibits143: Novaliq GmbH – Overview
Exhibits144: Novaliq GmbH – Product / Service
Exhibits145: Novaliq GmbH – Key offerings
Exhibits146: Novartis AG – Overview
Exhibits147: Novartis AG – Business segments
Exhibits148: Novartis AG – Key offerings
Exhibits149: Novartis AG – Segment focus
Exhibits150: Oasis Medical Inc. – Overview
Exhibits151: Oasis Medical Inc. – Product / Service
Exhibits152: Oasis Medical Inc. – Key offerings
Exhibits153: Otsuka Holdings Co. Ltd. – Overview
Exhibits154: Otsuka Holdings Co. Ltd. – Business segments
Exhibits155: Otsuka Holdings Co. Ltd. – Key offerings
Exhibits156: Otsuka Holdings Co. Ltd. – Segment focus
Exhibits157: Santen Pharmaceutical Co. Ltd. – Overview
Exhibits158: Santen Pharmaceutical Co. Ltd. – Product / Service
Exhibits159: Santen Pharmaceutical Co. Ltd. – Key offerings
Exhibits160: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits161: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits162: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits163: Viatris Inc. – Overview
Exhibits164: Viatris Inc. – Business segments
Exhibits165: Viatris Inc. – Key news
Exhibits166: Viatris Inc. – Key offerings
Exhibits167: Viatris Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations



★調査レポート[ドライアイ症候群治療薬のグローバル市場2023~2027:小売薬局、病院薬局、オンライン薬局] (コード:IRTNTR46644-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[ドライアイ症候群治療薬のグローバル市場2023~2027:小売薬局、病院薬局、オンライン薬局]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆